Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "US"

8399 News Found

B Braun unveils ready-to-use antibiotic system
R&D | December 08, 2025

B Braun unveils ready-to-use antibiotic system

DUPLEX’s two-compartment, PVC- and DEHP-free design keeps medication and diluent separate until activation


Paradigm Health to acquire Flatiron’s clinical research business
News | December 07, 2025

Paradigm Health to acquire Flatiron’s clinical research business

It's an acquisition that aims at forming one of the US's largest oncology trial networks


Granules’ packaging facility in US completes FDA inspection with zero observations
News | December 05, 2025

Granules’ packaging facility in US completes FDA inspection with zero observations

Granules Consumer Health serves as Granules’ front-end division for OTC products in the US


Lupin inks US licensing deal with Valorum for biosimilar Armlupeg
News | December 05, 2025

Lupin inks US licensing deal with Valorum for biosimilar Armlupeg

Valorum will advance the commercialization and distribution of Armlupeg in the United States


Industry-academia partnership key to advancing R&D agenda, says Dr. Jitendra Singh
R&D | December 05, 2025

Industry-academia partnership key to advancing R&D agenda, says Dr. Jitendra Singh

Growing patent filings and tier-2 innovators reflect expanding national research base


Zydus receives EIR for the injectable facility located at Jarod
Drug Approval | December 04, 2025

Zydus receives EIR for the injectable facility located at Jarod

This inspection was conducted following the warning letter issued by the USFDA


Briefs: Sun Pharma and Venus Remedies
News | December 04, 2025

Briefs: Sun Pharma and Venus Remedies

Sun Pharma to set up Rs. 3,000 crore greenfield formulations facility in MP


Stratasys completes US rollout of RadioMatrix 3D-printed imaging support material
Healthcare | December 04, 2025

Stratasys completes US rollout of RadioMatrix 3D-printed imaging support material

The technology is intended to support imaging-based training, protocol optimisation and surgical planning


Promotion of indigenous pharmaceutical manufacturing
Policy | December 04, 2025

Promotion of indigenous pharmaceutical manufacturing

PLI scheme for Bulk Drugs has a total budgetary outlay of Rs. 6,940 crore


US District Court grants summary judgement in Favour of SPARC for Sezaby PRV
News | December 03, 2025

US District Court grants summary judgement in Favour of SPARC for Sezaby PRV

FDA's withholding of the PRV was contrary to law because no drug product containing phenobarbital sodium was 'previously approved'